Marcela Tiburcio

Dr. Marcela Tiburcio

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2001 in Addiction
Verified
Journal Article
Closed access
PDF file
JOJim Orford
Jim Orford
GNGuillermina Natera
Guillermina Natera
RVRichard Velleman
Richard Velleman
ACAlex Copello
Alex Copello
NBNadia Bowie
Nadia Bowie
MTMarcela Tiburcio
Marcela Tiburcio

10 May 2017 in Addiction Science & Clinical Practice
Verified
Journal Article
Open access
PDF file
JGJoseph E. Glass
Joseph E. Glass
SASven Andréasson
Sven Andréasson
KBKatharine A. Bradley
Katharine A. Bradley
SFSara Wallhed Finn
Sara Wallhed Finn
EWEmily C. Williams
Emily C. Williams
RSRichard Saitz
Richard Saitz
In 2016, the International Network on Brief Interventions for Alcohol & Other Drugs convened a meeting titled “Rethinking alcohol interventions in health care”. The aims of the meeting were to synthesize recent evidence about screening and brief intervention and to set directions for research, practice, and policy in light of this evidence. Screening and brief intervention is efficacious in reducing self-reported alcohol consumption for some with unhealthy alcohol use, but there are gaps in evidence for its effectiveness. Because screening and brief intervention is not known to be efficacious for individuals with more severe unhealthy alcohol use, recent data showing the lack of evidence for referral to treatment as part of screening and brief intervention are alarming. While screening and brief intervention was designed to be a population-based approach, its reach is limited. Implementation in real world care also remains a challenge. This report summarizes practice, research, and policy recommendations and key research developments from our meeting. In order to move the field forward, a research agenda was proposed to (1) address evidence gaps in screening, brief intervention, and referral to treatment, (2) develop innovations to address severe unhealthy alcohol use within primary care, (3) describe the stigma of unhealthy alcohol use, which obstructs progress in prevention and treatment, (4) reconsider existing conceptualizations of unhealthy alcohol use that may influence health care, and (5) identify efforts needed to improve the capacity for addressing unhealthy alcohol consumption in all world regions.

2 March 2016 in Adicciones
Verified
Journal Article
Open access
PDF file
MTMarcela Tiburcio
Marcela Tiburcio
MRMa. Guadalupe Rosete-Mohedano
Ma. Guadalupe Rosete-Mohedano
GRGuillermina Natera Rey
Guillermina Natera Rey
NVNora Angélica Martínez Vélez
Nora Angélica Martínez Vélez
SGSilvia Carreño García
Silvia Carreño García
DCDaniel Pérez Cisneros
Daniel Pérez Cisneros
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), developed by the World Health Organization (WHO), has been used successfully in many countries, but there are few studies of its validity and reliability for the Mexican population. The objective of this study was to determine the psychometric properties of the self-administered ASSIST test in university students in Mexico. This was an ex post facto non-experimental study with 1,176 undergraduate students, the majority women (70.1%) aged 18-23 years (89.5%) and single (87.5%). To estimate concurrent validity, factor analysis and tests of reliability and correlation were carried out between the subscale for alcohol and AUDIT, those for tobacco and the Fagerström Test, and those for marijuana and DAST-20. Adequate reliability coefficients were obtained for ASSIST subscales for tobacco (alpha = 0.83), alcohol (alpha = 0.76), and marijuana (alpha = 0.73). Significant correlations were found only with the AUDIT (r = 0.71) and the alcohol subscale. The best balance of sensitivity and specificity of the alcohol subscale (83.8% and 80%, respectively) and the largest area under the ROC curve (81.9%) was found with a cutoff score of 8. The self-administered version of ASSIST is a valid screening instrument to identify at-risk cases due to substance use in this population.

1 December 2016 in Addictive Behaviors
Verified
Journal Article
Closed access
André Luiz Monezi AndradeAndré Luiz Monezi Andrade
André Luiz Monezi Andrade
RLRoseli Boerngen de Lacerda
Roseli Boerngen de Lacerda
HGHenrique Pinto Gomide
Henrique Pinto Gomide
TRTelmo Mota Ronzani
Telmo Mota Ronzani
LSLaisa Marcorela Andreoli Sartes
Laisa Marcorela Andreoli Sartes
MSMichael P. Schaub
Michael P. Schaub

16 May 2018 in Substance Use & Misuse
Verified
Journal Article
Closed access
MTMarcela Tiburcio
Marcela Tiburcio
MLMa. Asunción Lara
Ma. Asunción Lara
NMNora Angélica Martínez-Vélez
Nora Angélica Martínez-Vélez
MFMorise Fernández
Morise Fernández
AAAraceli Aguilar
Araceli Aguilar
Web-based cognitive-behavioral interventions to reduce substance use can be a useful low-cost treatment for a large number of people, and an attractive option in countries where a greater availability of treatment is needed. To evaluate the feasibility and initial effectiveness of a web-based cognitive-behavioral intervention for the reduction of substance use and depression compared with treatment as usual, with and without a printed self-help manual. Individuals seeking outpatient treatment for substance use were randomly assigned to one of the following: (1) the web-based Help Program for Drug Abuse and Depression (n = 23); (2) an in-person session with an addiction therapist and use of the Alcohol, Smoking, and Substance Involvement Screening Test Self-Help Strategies guide, followed by treatment as usual (n = 25), or (3) treatment ordinarily offered in the participating treatment centers (n = 26). The study took place in 2013-2014 (trial registration: ISRCTN25429892), and participants completed baseline, posttreatment, and 1-month follow-up evaluation interviews. Treatment retention and data availability were comparable in all three conditions. A reduction was observed from baseline to follow-up in average days of use [F(1,28) = 29.70, p < 0.001], severity of use [F(2,28) = 143.66, p < 0.001], and depressive symptomatology [F = (4)16.40, p < 0.001], independent of the type of treatment provided. The findings suggest that the web-based intervention to reduce substance abuse is feasible, although it is not more effective than other intervention modalities; its effectiveness must be evaluated in a larger sample. Attrition was a main limitation; future studies must improve retention and assess cost-effectiveness.

29 September 2016 in JMIR Mental Health
Verified
Journal Article
Open access
MTMarcela Tiburcio
Marcela Tiburcio
MLMa Asunción Lara
Ma Asunción Lara
AAAraceli Aguilar Abrego
Araceli Aguilar Abrego
MFMorise Fernández
Morise Fernández
NMNora Angélica Martínez-Vélez
Nora Angélica Martínez-Vélez
ASAlejandro Sánchez
Alejandro Sánchez
Background: The development of Web-based interventions for substance abuse in Latin America is a new field of interest with great potential for expansion to other Spanish-speaking countries. Objective: This paper describes a project aimed to develop and evaluate the usability of the Web-based Help Program for Drug Abuse and Depression (Programa de Ayuda para Abuso de Drogas y Depresión, PAADD, in Spanish) and also to construct a systematic frame of reference for the development of future Web-based programs. Methods: The PAADD aims to reduce substance use and depressive symptoms with cognitive behavioral techniques translated into Web applications, aided by the participation of a counselor to provide support and guidance. This Web-based intervention includes 4 steps: (1) My Starting Point, (2) Where Do I Want to Be? (3) Strategies for Change, and (4) Maintaining Change. The development of the program was an interactive multistage process. The first stage defined the core structure and contents, which were validated in stage 2 by a group of 8 experts in addiction treatment. Programming of the applications took place in stage 3, taking into account 3 types of end users: administrators, counselors, and substance users. Stage 4 consisted of functionality testing. In stage 5, a total of 9 health professionals and 20 drug users currently in treatment voluntarily interacted with the program in a usability test, providing feedback about adjustments needed to improve users’ experience. Results: The main finding of stage 2 was the consensus of the health professionals about the cognitive behavioral strategies and techniques included in PAADD being appropriate for changing substance use behaviors. In stage 5, the health professionals found the functionalities easy to learn; their suggestions were related to the page layout, inclusion of confirmation messages at the end of activities, avoiding “read more” links, and providing feedback about every activity. On the other hand, the users said the information presented within the modules was easy to follow and suggested more dynamic features with concrete instructions and feedback. Conclusions: The resulting Web-based program may have advantages over traditional face-to-face therapies owing to its low cost, wide accessibility, anonymity, and independence of time and distance factors. The detailed description of the process of designing a Web-based program is an important contribution to others interested in this field. The potential benefits must be verified in specific studies. Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 25429892; http://www.controlled-trials.com/ISRCTN25429892 (Archived by WebCite at http://www.webcitation.org/6ko1Fsvym)